Kagawa Todd F, O'toole Paul W, Cooney Jakki C
Department of Chemical and Environmental Sciences, and Materials and Surfaces Sciences Institute, University of Limerick, Limerick, Ireland.
Mol Microbiol. 2005 Aug;57(3):650-66. doi: 10.1111/j.1365-2958.2005.04708.x.
This study presents evidence for a novel protease-protease inhibitor couple, SpeB-Spi, in the human pathogen Streptococcus pyogenes. The gene for the inhibitor Spi is located directly downstream of the gene for the streptococcal cysteine protease SpeB. Spi is 37% identical and 70% similar to the sequence of the SpeB propeptide, suggesting that Spi and the SpeB propeptide might bind to SpeB in an analogous manner. Secondary structure predictions and molecular modelling suggested that Spi would adopt a structure similar to the SpeB propeptide. The spi gene was co-transcribed with speB on the 1.7 knt and 2.2 knt transcripts previously identified for speB. The Spi protein was purified by SpeB-affinity chromatography from the S. pyogenes cytoplasm. Recombinant Spi was produced and purified, and shown to bind to SpeB and to inhibit its protease activity. Although a similar genetic arrangement of protease and inhibitor is present in staphylococci, this is the first example of an inhibitor molecule that is a structural homologue of the cognate propeptide, and which is genetically linked to the protease gene. Thus, this represents a novel system whereby bacteria may control the intracellular activity of their proteases.
本研究为人类病原体化脓性链球菌中一种新型蛋白酶 - 蛋白酶抑制剂组合SpeB - Spi提供了证据。抑制剂Spi的基因直接位于链球菌半胱氨酸蛋白酶SpeB基因的下游。Spi与SpeB前肽序列有37%的同一性和70%的相似性,这表明Spi和SpeB前肽可能以类似方式与SpeB结合。二级结构预测和分子建模表明,Spi将采用与SpeB前肽相似的结构。spi基因与speB在先前为speB鉴定的1.7 kb和2.2 kb转录本上共同转录。Spi蛋白通过SpeB亲和层析从化脓性链球菌细胞质中纯化出来。重组Spi被生产并纯化,结果表明它能与SpeB结合并抑制其蛋白酶活性。虽然葡萄球菌中存在类似的蛋白酶和抑制剂基因排列,但这是抑制剂分子作为同源前肽的结构同源物且与蛋白酶基因存在遗传联系的首个例子。因此,这代表了一种细菌可能控制其蛋白酶细胞内活性的新系统。